1,953 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

GRPH

Graphite Bio
US$22.26539.7%861.6%US$190.4mn/aPB7.1xE36.4%n/a

BJP

Beit Jala Pharmaceutical
د.أ2.800%n/aد.أ19.6mn/aPE9.8xn/a3.6%

CHOSA

Chosa Oncology
SEK 0.530%-59.2%SEK 34.4mn/aPB2xn/an/a

C4XD

C4X Discovery Holdings
UK£0.1245.9%-16.4%UK£30.3mn/aPE2.9xE-88.3%n/a

ALPN

Alpine Immune Sciences
US$64.970.03%518.2%US$4.5bUS$62.00PS78.9xE-9.9%n/a

NGM

NGM Biopharmaceuticals
US$1.54-3.1%-59.8%US$128.5mUS$1.55PS29.1xE14.7%n/a

2309

CMIC HOLDINGS
JP¥2,644.000.2%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

EQRX

EQRx
US$2.34-5.3%-36.2%US$1.1bn/aPB1xS123.3%n/a

TALS

Talaris Therapeutics
US$27.20-4.9%91.5%US$553.2mUS$200.00PB3.7xn/an/a

YMTX

Yumanity Therapeutics
US$13.23-8.3%-41.3%US$143.6mn/aPS29.7xn/an/a

KDNY

Chinook Therapeutics
US$40.390.3%95.7%US$2.9bUS$40.09PS495.8xE22.6%n/a

ELTX

Elicio Therapeutics
US$4.53-5.4%-53.2%US$50.4mUS$10.00PB10xn/an/a

VNDA

Vanda Pharmaceuticals
US$6.17-0.8%-5.2%US$366.6mUS$8.11PS2xE83.5%n/a

NRIX

Nurix Therapeutics
US$21.09-3.1%124.1%US$1.5bUS$28.42PS21.8xE-2.2%n/a

TRVI

Trevi Therapeutics
US$2.974.6%28.6%US$208.5mUS$7.40PB2.9xE-9.1%n/a

TARA

Protara Therapeutics
US$2.320.9%-14.4%US$49.2mUS$27.80PB0.8xE0.5%n/a

ATXS

Astria Therapeutics
US$11.471.2%34.5%US$640.3mUS$24.71PB2.3xE22.5%n/a

KOD

Kodiak Sciences
US$3.020.3%-6.8%US$163.4mUS$3.50PB0.7xE-14.5%n/a

MURA

Mural Oncology
US$3.43-1.4%n/aUS$58.4mUS$13.00PB0.2xn/an/a

SGMT

Sagimet Biosciences
US$3.16-7.1%-78.9%US$104.4mUS$35.80PS50.4xE-29.1%n/a

SEMG

Seach Medical Group
₪1.50-0.5%-5.7%₪51.0mn/aPB0.7xn/an/a

KMDA

Kamada
₪21.120.9%13.7%₪1.2bn/aPE26.7xE21.6%n/a

FRE

Firebrick Pharma
AU$0.050%-74.4%AU$9.8mn/aPS5.4xn/an/a

BLAU3

Blau Farmacêutica
R$11.10-1.7%-45.7%R$2.0bR$13.54PE8.3xE11.0%6.7%
Page 1 of 82
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.